scholarly article | Q13442814 |
P50 | author | Joseph R Arron | Q61147913 |
Susan Lynch | Q89867375 | ||
P2093 | author name string | David F Choy | |
Yvonne J Huang | |||
Homer Boushey | |||
Jeffrey M Harris | |||
Snehal Nariya | |||
P2860 | cites work | Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis | Q21128781 |
Disordered microbial communities in asthmatic airways | Q21562589 | ||
Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF) | Q24319867 | ||
Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
Statistical significance for genomewide studies | Q24681264 | ||
Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum | Q24681753 | ||
UniFrac: a new phylogenetic method for comparing microbial communities | Q29547435 | ||
Induction of colonic regulatory T cells by indigenous Clostridium species | Q29547701 | ||
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences | Q29615050 | ||
Picante: R tools for integrating phylogenies and ecology | Q29616782 | ||
An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea | Q29617497 | ||
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota | Q29618128 | ||
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program | Q30433207 | ||
Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids | Q30480169 | ||
Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation | Q33256628 | ||
High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment | Q33276592 | ||
Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data | Q33685280 | ||
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma | Q33782854 | ||
Independent filtering increases detection power for high-throughput experiments | Q34006510 | ||
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. | Q34058686 | ||
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense | Q34087551 | ||
Deep-sea oil plume enriches indigenous oil-degrading bacteria | Q34132984 | ||
Man's best friend? The effect of pet ownership on house dust microbial communities | Q34206988 | ||
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice | Q34820539 | ||
Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
Asthma-associated differences in microbial composition of induced sputum | Q35494072 | ||
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients | Q36765753 | ||
T-helper type 2-driven inflammation defines major subphenotypes of asthma. | Q37343774 | ||
Th17 cells: new players in asthma pathogenesis | Q37849819 | ||
Severe asthma: from characteristics to phenotypes to endotypes | Q37976476 | ||
Severe refractory asthma: an update | Q38133489 | ||
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma | Q38171268 | ||
The impact of azithromycin therapy on the airway microbiota in asthma | Q42717651 | ||
IL-17 enhances chemokine gene expression through mRNA stabilization | Q42824985 | ||
Analysis of the microbial gene landscape and transcriptome for aromatic pollutants and alkane degradation using a novel internally calibrated microarray system | Q45286348 | ||
Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response | Q46479336 | ||
Rapid quantification and taxonomic classification of environmental DNA from both prokaryotic and eukaryotic origins using a microarray. | Q52563829 | ||
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma | Q60147711 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | asthma | Q35869 |
microbiome | Q1330402 | ||
P304 | page(s) | 874-884 | |
P577 | publication date | 2015-07-26 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | The airway microbiome in patients with severe asthma: Associations with disease features and severity | |
P478 | volume | 136 |
Q89494857 | A Human Lung-Associated Streptomyces sp. TR1341 Produces Various Secondary Metabolites Responsible for Virulence, Cytotoxicity and Modulation of Immune Response |
Q38837433 | Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches. |
Q91945328 | Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases |
Q64111701 | Airway Microbiome in Different Inflammatory Phenotypes of Asthma: A Cross-Sectional Study in Northeast China |
Q64124389 | Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer |
Q38890722 | Airway Microbiota and the Implications of Dysbiosis in Asthma |
Q35989768 | Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes |
Q99565412 | Altered vaginal microbiome and relative co-abundance network in pregnant women with penicillin allergy |
Q38860462 | Analysis and Interpretation of the Human Microbiome |
Q40501188 | Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis |
Q39313937 | Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation |
Q28365058 | Asthma and the microbiome: defining the critical window in early life |
Q43504466 | Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction |
Q33707521 | Bacteria isolated from lung modulate asthma susceptibility in mice |
Q55378029 | Bacterial biogeography of adult airways in atopic asthma. |
Q52371735 | Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection. |
Q37677661 | Beyond Hygiene: Commensal Microbiota and Allergic Diseases |
Q28067227 | Breathing Better Through Bugs: Asthma and the Microbiome |
Q35896222 | COMPUTATIONAL APPROACHES TO STUDY MICROBES AND MICROBIOMES. |
Q41993348 | Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences |
Q62589151 | Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases |
Q47755641 | Different functional genes of upper airway microbiome associated with natural course of childhood asthma. |
Q100395069 | Distinct lung microbiota associate with HIV-associated chronic lung disease in children |
Q26768646 | Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma? |
Q36302757 | Dynamic changes of the respiratory microbiota and its relationship to fecal and blood microbiota in healthy young cats |
Q26741488 | Elucidating novel disease mechanisms in severe asthma |
Q38801764 | Eosinophils, probiotics, and the microbiome. |
Q91675729 | Epithelial barrier repair and prevention of allergy |
Q41117550 | Exposure to ambient particulate matter alters the microbial composition and induces immune changes in rat lung |
Q39094699 | Extracellular Vesicles, a Key Mediator to Link Environmental Microbiota to Airway Immunity |
Q38795934 | Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment |
Q36610854 | Feces Derived Allergens of Tyrophagus putrescentiae Reared on Dried Dog Food and Evidence of the Strong Nutritional Interaction between the Mite and Bacillus cereus Producing Protease Bacillolysins and Exo-chitinases |
Q39315816 | Fit-for-purpose biomarker immunoassay qualification and validation: three case studies |
Q93037597 | Functional effects of the microbiota in chronic respiratory disease |
Q55428575 | Gut microbiota components are associated with fixed airway obstruction in asthmatic patients living in the tropics. |
Q57070672 | Gut microbiota relationships to lung function and adult asthma phenotype: a pilot study |
Q54956738 | Heterogeneity of Microbiota Dysbiosis in Chronic Rhinosinusitis: Potential Clinical Implications and Microbial Community Mechanisms Contributing to Sinonasal Inflammation. |
Q51146459 | Host-Microbe Interactions in Airway Disease: toward Disease Mechanisms and Novel Therapeutic Strategies. |
Q47948534 | IL-22 induces Reg3γ and inhibits allergic inflammation in house dust mite-induced asthma models. |
Q46176492 | Incorporating the airway microbiome into asthma phenotyping: Moving toward personalized medicine for noneosinophilic asthma |
Q92109240 | Influences on allergic mechanisms through gut, lung, and skin microbiome exposures |
Q36913746 | Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis |
Q90245076 | Integrative study of the upper and lower airway microbiome and transcriptome in asthma |
Q64076177 | Laryngotracheal Microbiota in Adult Laryngotracheal Stenosis |
Q54968466 | Long-term exposure to low-dose Haemophilus influenzae during allergic airway disease drives a steroid-resistant neutrophilic inflammation and promotes airway remodeling. |
Q91720343 | Looking Higher: Is It Prime Time for the Oral-Lung Axis in HIV-related Lung Disease? |
Q33833225 | Lung Microbiota and Its Impact on the Mucosal Immune Phenotype. |
Q93351736 | Lung inflammation and disease: A perspective on microbial homeostasis and metabolism |
Q57494125 | Lung tissue microbial profile in lung cancer is distinct from emphysema |
Q39402899 | Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma. |
Q46244354 | Microbial diversity within the airway microbiome in chronic pediatric lung diseases |
Q94545387 | Microbiome Composition and Its Impact on the Development of Allergic Diseases |
Q64114415 | Microbiome Dependent Regulation of T and Th17 Cells in Mucosa |
Q47228960 | Microbiome and asthma |
Q37739364 | Microbiome effects on immunity, health and disease in the lung |
Q99582945 | Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms |
Q91782587 | Natural Killer Cells in the Lungs |
Q36200942 | Natural products as mediators of disease. |
Q55409227 | Novel human microbe-disease associations inference based on network consistency projection. |
Q88298052 | Obesity and asthma |
Q64953300 | Obesity and severe asthma. |
Q35926923 | Obesity, Asthma, and the Microbiome |
Q36288824 | Persistent asthma phenotype related with late-onset, high atopy, and low socioeconomic status in school-aged Korean children |
Q91633083 | Pharmacogenetics of Pediatric Asthma: Current Perspectives |
Q33758290 | Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients |
Q47704287 | Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes |
Q38639737 | Potential of Health and Demographic Surveillance System in Asthma and Chronic Obstructive Pulmonary Disease Microbiome Research |
Q38678093 | Precision respiratory medicine and the microbiome |
Q93162377 | Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma |
Q38850302 | Salivary microbiome of an urban Indian cohort and patterns linked to subclinical inflammation |
Q60921619 | Sex-Specific Association between Childhood BMI Trajectories and Asthma Phenotypes |
Q91895123 | Smoking and microbiome in oral, airway, gut and some systemic diseases |
Q46438712 | Study of the Lung Microbiome. Have We Reached the End of the Beginning? |
Q64090843 | The ABCs of wheeze: Asthma and bacterial communities |
Q90094635 | The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks |
Q44953373 | The Lung Microbiome and Airway Disease |
Q38622649 | The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma |
Q47638694 | The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma. |
Q89787316 | The Role of Lung and Gut Microbiota in the Pathology of Asthma |
Q47120731 | The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis |
Q92425141 | The crosstalk between microbiome and asthma: Exploring associations and challenges |
Q38911712 | The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases |
Q90003618 | The influence of the microbiome on respiratory health |
Q38750982 | The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology |
Q38949256 | The microbiome in asthma |
Q90541039 | The microbiome in asthma: Role in pathogenesis, phenotype, and response to treatment |
Q88003632 | The nasal microbiome in asthma |
Q92024474 | The upper-airway microbiota and loss of asthma control among asthmatic children |
Q58704177 | Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status |
Q99413079 | Type 2-high asthma is associated with a specific indoor mycobiome and microbiome |
Q37272779 | Vitamin D and allergic airway disease shape the murine lung microbiome in a sex-specific manner |
Search more.